Clinical Trial Update: Drug-eluting Stents to Treat Unprotected Coronary Left Main Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating drug-eluting stents for unprotected left main coronary artery disease has completed. The update confirms the study status as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Left Main Coronary Artery Disease

Drugs mentioned

• drug-eluting stent (unspecified)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Coronary Disease | Phase 4 | Status: COMPLETED